Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
Phase 2
- Conditions
- Myelodysplastic Syndromes
- First Posted Date
- 2004-08-12
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Providence Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT00003123
- Locations
- 🇺🇸
Osteopathic Medical Oncology and Hematology, P.C., Clinton Township, Michigan, United States
🇺🇸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Henry Ford Hospital, Detroit, Michigan, United States
News
No news found